Recent advances in point-of-care testing of COVID-19
S Lee, L Bi, H Chen, D Lin, R Mei, Y Wu… - Chemical Society …, 2023 - pubs.rsc.org
Advances in microfluidic device miniaturization and system integration contribute to the
development of portable, handheld, and smartphone-compatible devices. These …
development of portable, handheld, and smartphone-compatible devices. These …
The importance of sulfur-containing motifs in drug design and discovery
Introduction Sulfur-containing functional groups are privileged motifs that occur in various
pharmacologically effective substances and several natural products. Various functionalities …
pharmacologically effective substances and several natural products. Various functionalities …
Diagnostic approaches for COVID-19: lessons learned and the path forward
Coronavirus disease 2019 (COVID-19) is a transmitted respiratory disease caused by the
infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although …
infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although …
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
P Kongsuphol, H Jia, HL Cheng, Y Gu… - Communications …, 2021 - nature.com
Abstract Background Neutralizing antibodies (NAbs) prevent pathogens from infecting host
cells. Detection of SARS-CoV-2 NAbs is critical to evaluate herd immunity and monitor …
cells. Detection of SARS-CoV-2 NAbs is critical to evaluate herd immunity and monitor …
Beyond wax printing: The future of paper analytical device fabrication
RM Roller, M Lieberman - Sensors and Actuators B: Chemical, 2023 - Elsevier
Many microfluidic “lab on paper” devices have been demonstrated for point-of-use
applications, but scalable fabrication methods are necessary for these devices to make it …
applications, but scalable fabrication methods are necessary for these devices to make it …
Rapid and sensitive SARS-CoV-2 detection using a homogeneous fluorescent immunosensor Quenchbody with crowding agents
B Zhu, N Nosaka, S Kanamaru, J Dong, Y Dai, A Inoue… - Analyst, 2022 - pubs.rsc.org
Antigen tests for SARS-CoV-2 are widely used by the public during the ongoing COVID-19
pandemic, which demonstrates the societal impact of homogeneous immunosensor-related …
pandemic, which demonstrates the societal impact of homogeneous immunosensor-related …
Nanobody-functionalized cellulose for capturing SARS-CoV-2
The highly transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has infected more than 253 million people, claiming∼ 5.1 million lives to date. Although …
has infected more than 253 million people, claiming∼ 5.1 million lives to date. Although …
Multiplex and Ultrasensitive Detection of Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A/B Nucleocapsid Proteins Based on Nanometer-Sized …
Infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
influenza A (Flu A), and influenza B (Flu B) show similar clinical symptoms, such as cough …
influenza A (Flu A), and influenza B (Flu B) show similar clinical symptoms, such as cough …
Exponential amplification using photoredox autocatalysis
S Kim, A Martínez Dibildox… - Journal of the …, 2021 - ACS Publications
Exponential molecular amplification such as the polymerase chain reaction is a powerful
tool that allows ultrasensitive biodetection. Here, we report a new exponential amplification …
tool that allows ultrasensitive biodetection. Here, we report a new exponential amplification …
Microfluidic immunoassays for point-of-care testing of SARS-CoV-2 antigens and antibodies
C Li, W Zhou, AG Ruiz, Y Mohammadi, Q Li… - TrAC Trends in …, 2024 - Elsevier
The point-of-care testing (POCT) of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) antigens and antibodies is of great significance in screening the infection and …
CoV-2) antigens and antibodies is of great significance in screening the infection and …